BridgeMD
New treatment option for Ischemic Heart Disease
Official title Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease
ClinicalTrials.gov ID: NCT05788666
What this study is testing
- What it's testing
- This study seeks to expand the use of the NYU GeriKit mobile application ("app") in a diverse range of settings to better phenotype older patients, which will enhance both research and patient care.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 75 to 100
You may be able to join if
- Age ≥ 75
- Currently hospitalized for acute mycardial infarction (AMI), percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG); or...
- Capable of self-consent
- Understand and are able to perform study procedures in English
You likely can't join if
- Non-ambulatory
- Moderate or severe cognitive impairment (operationalized as known diagnosis of dementia)
- Unable or unwilling to consent
- Incarcerated
- Unable to use complete assessments in English
- Unable to complete geriatric assessment for other reasons
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 75 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.